Neurologic manifestations associated with parvovirus B19 infection

Clinical Infectious Diseases

Volumn 48, Issue 12, 2009, Pages 1713-1723

  Douvoyiannis, Miltiadis ^a   Litman, Nathan ^a   Goldman, David L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; AZATHIOPRINE; CHLORAL; DEXAMETHASONE; GABAPENTIN; GANCICLOVIR; HALOPERIDOL; IMMUNOGLOBULIN; MANNITOL; METHYLPREDNISOLONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; PREGABALIN; STEROID; TEMAZEPAM; VIRUS ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; ATAXIA; BRACHIAL PLEXUS NEUROPATHY; CARPAL TUNNEL SYNDROME; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHOREA; CLINICAL FEATURE; CROHN DISEASE; DNA DETERMINATION; DRUG WITHDRAWAL; ENCEPHALITIS; EPILEPTIC STATE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IMMUNOCOMPETENCE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MENINGOENCEPHALITIS; MONONEUROPATHY MULTIPLEX; NEUROLOGIC DISEASE; NEUROPATHY; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARVOVIRUS; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SEIZURE; SPHEROCYTOSIS; STROKE; SYMPTOMATOLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PERIPHERAL NERVOUS SYSTEM DISEASES; PREVALENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 66949144407     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/599042     Document Type: Article

References (69)

1. Anderson MJ, Jones SE, Fisher-Hoch SP, et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1983; 1:1378.
2. Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. J Intern Med 2006;260:285-304.
3. CohenBJ, BuckleyMM. The prevalence ofantibodyto humanparvovirus B19 in England and Wales. J Med Microbiol 1988;25:151-3.
4. Koch WC. Fifth (human parvovirus) and sixth (herpesvirus 6) diseases. Curr Opin Infect Dis 2001; 14:343-56.
5. Kerr JR, Bracewell J, Laing I, et al. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection. J Rheumatol 2002; 29:595-602.
6. Balfour HH Jr, Schiff GM, Bloom JE. Encephalitis associated with erythema infectiosum. J Pediatr 1970; 77:133-6.
7. Breese C, Horner FA. Encephalopathy with erythema infectiosum. Am J Dis Child 1977; 131:65-7.
8. Sarff LD, Platt LH, McCracken GH Jr. Cerebrospinal fluid evaluation in neonates: comparison of high-risk infants with and without meningitis. J Pediatr 1976; 88:473-7.
9. Oshima K, Kikuchi A, Mochizuki S, Arai T, Oishi T, Hanada R. Acute encephalopathy with human parvovirus B19 infection in hereditary spherocytosis. Pediatr Infect Dis J 2008;27:651-2.
10. Fong CY, de Sousa C. Childhood chorea-encephalopathy associated with human parvovirus B19 infection. Dev Med Child Neurol 2006;48:526-8.
11. Zerbini M, Musiani M, Venturoli S, et al. Different syndromes associated with B19 parvovirus viraemia in paediatric patients: report of four cases. Eur J Pediatr 1992; 151:815-7.
12. Yoto Y, Kudoh T, Asanuma H, et al. Transient disturbance of consciousness and hepatic dysfunction associated with human parvovirus B19 infection. Lancet 1994;344:624-5.
13. Watanabe T, Satoh M, Oda Y. Human parvovirus B19 encephalopathy. Arch Dis Child 1994;70:71.
14. Watanabe T. Ulcerative colitis that developed 8 years after human parvovirus B19 encephalopathy. Eur J Pediatr 2004; 163:341-2.
15. Skaff PT, Labiner DM. Status epilepticus due to human parvovirus B19 encephalitis in an immunocompetent adult. Neurology 2001 ; 57:1336-7.
16. Haseyama K, Kudoh T, Yoto Y, Suzuki N, Chiba S. Detection ofhuman parvovirus B19 DNA in cerebrospinal fluid. Pediatr Infect Dis J 1997; 16:324-6.
17. Kerr JR, Barah F, Chiswick ML, et al. Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae. J Neurol Neurosurg Psychiatry 2002; 73:739-46.
18. Steinfort DP, Dixon B. Parvovirus encephalitis and pneumonia in an immunocompetent adult. Intern Med J 2006; 36:209-10.
19. Tonnellier M, Bessereau J, Carbonnell N, et al. A possible parvovirus B19 encephalitis in an immunocompetent adult patient. J Clin Virol 2007;38:186-7.
20. Druschky K, Walloch J, Heckmann J, Schmidt B, Stefan H, Neundorfer B. Chronic parvovirus B-19 meningoencephalitis with additional detection of Epstein-Barr virus DNA in the cerebrospinal fluid of an immunocompetent patient. J Neurovirol 2000; 6:418-22.
21. Yazawa S, Kawasaki S, Fujimoto C, Ohi T. Case report of meningo- encephalitis during a concomitant mumps and parvovirus B19 infetion. Clin Neurol Neurosurg 2002; 104:380-2.
22. Erol I, Alehan F, Yalcin K. Refractory status epilepticus owing to human parvovirus B19 encephalitis in a child. J Child Neurol 2006; 21:820-2.
23. Bonvicini F, Marinacci G, Pajno MC, Gallinella G, Musiani M, Zerbini M. Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman. Clin Infect Dis 2008; 47:385-7.
24. Cassinotti P, Schultze D, Schlageter P, Chevili S, Siegl G. Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient. Eur J Clin Microbiol Infect Dis 1993; 12:701-4.
25. Suzuki N, Terada S, Inoue M. Neonatal meningitis with human parvovirus B19 infection. Arch Dis Child Fetal Neonatal Ed 1995;73: F196-7.
26. Okumura A, Ichikawa T. Aseptic meningitis caused by human parvovirus B19. Arch Dis Child 1993;68:784-5.
27. Tsuji A, Uchida N, Asamura S, Matsunaga Y, Yamazaki S. Aseptic meningitis with erythema infectiosum. Eur J Pediatr 1990; 149:449-50.
28. Tabak F, Mert A, Ozturk R, Koksal V, Akbas I, Aktuglu Y. Prolonged fever caused by parvovirus B19-induced meningitis: case report and review. Clin Infect Dis 1999; 29:446-7.
29. Pereira AC, Barros RA, do Nascimento JP, de Oliveira SA. Two family members with a syndrome of headache and rash caused by human parvovirus B19. Braz J Infect Dis 2001;5:37-9.
30. Akin M, Carman KB, Karaturk AH, Ceran O. Mumps-like syndrome owing to parvovirus B19: a brief report. Ann Trop Paediatr 2002;22:57-8.
31. Mandrioli J, Portolani M, Cortelli P, Sola P. Middle cerebral artery thrombosis in course of parvovirus B19 infection in a young adult: a new risk factor for stroke? J Neurovirol 2004; 10:71-4.
32. Guidi B, Bergonzini P, Crisi G, Frigieri G, Portolani M. Case of stroke in a 7-year-old male after parvovirus B19 infection. Pediatr Neurol 2003; 28:69-71.
33. Hsu D, Sandborg C, Hahn JS. Frontal lobe seizures and uveitis associated with acute human parvovirus B19 infection. J Child Neurol 2004; 19:304-6.
34. Shimizu Y, Ueno T, Komatsu H, Takada H, Nunoue T. Acute cerebellar ataxia with human parvovirus B19 infection. Arch Dis Child 1999; 80:72-3.
35. Minohara Y, Koitabashi Y, Kato T, et al. A case of Guillain-Barre syndrome associated with human parvovirus B19 infection. J Infect 1998; 36:327-8.
36. Denning DW, Amos A, Rudge P, Cohen BJ. Neuralgic amyotrophy due to parvovirus infection. J Neurol Neurosurg Psychiatry 1987; 50:641-2.
37. Walsh KJ, Armstrong RD, Turner AM. Brachial plexus neuropathy associated with human parvovirus infection. Br Med J Clin Res Ed 1988; 296:896.
38. Faden H, Gary GW Jr, Anderson LJ. Chronic parvovirus infection in a presumably immunologically healthy woman. Clin Infect Dis 1992;15:595-7.
39. Pellas F, Olivares JP, Zandotti C, Delarque A. Neuralgic amyotrophy after parvovirus B19 infection. Lancet 1993; 342:503-4.
40. Staud R, Davidson RA, Corman LC. Brachial plexitis in a patient with acute parvovirus B19 infection. Br J Rheumatol 1995;34:480-1.
41. Maas JJ, Beersma MF, Haan J, Jonkers GJ, Kroes AC. Bilateral brachial plexus neuritis following parvovirus B19 and cytomegalovirus infection. Ann Neurol 1996; 40:928-32.
42. Kirchhoff-Moradpour A, Huzly D, Korinthenberg R, Berner R. Neuralgic amyotrophy associated with parvovirus B19 infection in a child. Eur J Pediatr 2001; 160:200-1.
43. Martinon-Torres F, Seara MJ, Del Rio Pastoriza I, Mata MB, Castro-Gago M. Parvovirus B19 infection complicated by peripheral facial palsy and parotitis with intraparotid lymphadenitis. Pediatr Infect Dis J 1999; 18:307-8.
44. Soares-Fernandes JP, Mare R. Isolated velopalatine paralysis associated with parvovirus B19 infection. Arq Neuropsiquiatr 2006; 64:603-5.
45. Aguilar-Bernier M, Bassas-Vila J, Torne-Gutierrez JI, Martinez-Garcia G, Aragoneses-Fraile H, Miranda-Romero A. Presence of perineuritis in a case of papular purpuric gloves and socks syndrome associated with mononeuritis multiplex attributable to B19 parvovirus. J Am Acad Dermatol 2006; 54:896-9.
46. Rabar D, Peyramond D. Parvovirus B19 infection revealed by prolonged dysesthesia [in French]. Med Mal Infect 2005;35:91-4.
47. Samii K, Cassinotti P, de Freudenreich J, Gallopin Y, Le Fort D, Stalder H. Acute bilateral carpal tunnel syndrome associated with human parvovirus B19 infection. Clin Infect Dis 1996;22:162-4.
48. Musiani M, Manaresi E, Gallinella G, Zerbini M. Persistent parvovirus B19 infection resulting in carpal tunnel syndrome. J Clin Pathol 2007;60:1177-8.
49. Sinclair JP, Croxson MC, Thomas SM, Teague LR, Mauger DC. Chronic parvovirus B19 meningitis in a child with acute lymphocytic leukemia. Pediatr Infect Dis J 1999; 18:395-6.
50. Heegaard ED, Peterslund NA, Hornsleth A. Parvovirus B19 infection associated with encephalitis in a patient suffering from malignant lymphoma. Scand J Infect Dis 1995;27:631-3.
51. Wierenga KJ, Serjeant BE, Serjeant GR. Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease. J Pediatr 2001; 139:438-42.
52. Bakhshi S, Sarnaik SA, Becker C, Shurney WW, Nigro M, Savasan S. Acute encephalopathy with parvovirus B19 infection in sickle cell disease. Arch Dis Child 2002; 87:541-2.
53. Lefrere J, Oliver C, Courouce AM, Soulier JP. Erythroblastopenia and febrile meningeal syndrome [in French]. Presse Med 1985; 14:228-9.
54. Koduri PR, Naides SJ. Aseptic meningitis caused by parvovirus B19. Clin Infect Dis 1995; 21:1053.
55. Nolan RC, Chidlow G, French MA. Parvovirus B19 encephalitis presenting as immune restoration disease after highly active antiretroviral therapy for human immunodeficiency virus infection. Clin Infect Dis 2003;36:1191-4.
56. Moretti MV, Abbate I, Sciarrone MR, et al. Acute infection with parvovirus B19 manifesting as brain stem encephalitis. Infect Med 2008;25:173-9.
57. Laurenz M, Winkelmann B, Roigas J, Zimmering M, Querfeld U, Muller D. Severe parvovirus B19 encephalitis after renal transplantation. Pediatr Transplant 2006; 10:978-81.
58. Bilge I, Sadikoglu B, Emre S, Sirin A, Aydin K, Tatli B. Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient. Pediatr Nephrol 2005; 20:529-33.
59. Gennery AJ, Cant A, Forsyth RJ. Development of parainfectious op- soclonus in an infant by a non-humoral immune mechanism. Dev Med Child Neurol 2001;43:213-4.
60. Nigro G, D'Eufemia P, Zerbini M, Krzysztofiak A, Finocchiaro R, Giar- dini O. Parvovirus B19 infection in a hypogammaglobulinemic infant with neurologic disorders and anemia: successful immunoglobulin therapy. Pediatr Infect Dis J 1994; 13:1019-21.
61. Puechal X, Hilliquin P, Kahan A, Menkes CJ. Neuralgic amyotrophy and polyarthritis caused by parvovirus B19 infection. Ann Rheum Dis 1998; 57:262.
62. Faden H, Gary GW Jr, Korman M. Numbness and tingling of fingers associated with parvovirus B19 infection. J Infect Dis 1990; 161:354-5.
63. Craze JL, Salisbury AJ. Prenatal stroke associated with maternal par- vovirus infection. Dev Med Child Neurol 1996; 38:84-5.
64. Torok T. Human parvovirus B19. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. Philadelphia: WB Saunders, 2001:779-811.
65. Isumi H, Nunoue T, Nishida A, Takashima S. Fetal brain infection with human parvovirus B19. Pediatr Neurol 1999; 21:661-3.
66. Hobbs JA. Detection of adeno-associated virus 2 and parvovirus B19 in the human dorsolateral prefrontal cortex. J Neurovirol 2006;12:190-9.
67. Musiani M, Zerbini M, Gentilomi G, Plazzi M, Gallinella G, Venturoli S. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 1995; 172:1360-3.
68. Barah F, Vallely PJ, Chiswick ML, Cleator GM, Kerr JR. Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet 2001 ; 358:729-30.
69. Barah F, Vallely PJ, Cleator GM, Kerr JR. Neurological manifestations of human parvovirus B19 infection. Rev Med Virol 2003; 13:185-99.